Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit.

Maria SepúlvedaSara LlufriuEugenia Martínez-HernándezMartí CatalàMontse ArtolaAna HernandoCarmen MontejoIrene Pulido-ValdeolivasEloy Martínez-HerasMar GuaspElisabeth SolanaLaura LlansóDomingo EscuderoMarta AldeaClara PratsFrancesc GrausYolanda BlancoAlbert Saiz

Published in: Neurology(R) neuroimmunology & neuroinflammation (2021)

In the studied MS cohort, the incidence of COVID-19 was higher than that of the general population; however, most patients did not require hospitalization and had a good outcome despite the frequent presence of comorbidities and treatment with DMT.

Keyphrases

mass spectrometry
coronavirus disease
multiple sclerosis
sars cov
ms ms
end stage renal disease
risk factors
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis